The world’s spotlight turns once again to Düsseldorf as MEDICA 2025, one of the largest and most influential medical trade fairs worldwide, officially opened on November 17.At MEDICA 2025, MedicalSystem presents its fully upgraded IVD total solutions, demonstrating the strength of China’s precision diagnostics on a global stage.

MedicalSystem showcases a comprehensive IVD solutions covering clinical chemistry, chemiluminescence, hematology, and VAP precision lipid testing solutions. All featured products have earned certifications, highlighting the company’s strong R&D capabilities and its commitment to delivering customer-driven innovations that empower healthcare providers worldwide.

MedicalSystem highlighted its core patented VAP Precision Lipid Profiling Solution. Using vertical density-gradient ultracentrifugation, VAP directly measures cholesterol and particle concentrations across all lipoprotein subfractions, delivering accurate lipids profiling.As a key tool for evaluating cardiovascular and residual risk, it supports more precise risk prediction and personalized treatment, advancing global health management.

Booth 1A38 attracted a steady flow of global visitors, with productive discussions held with partners, distributors, and potential clients on product strengths, market needs, and collaboration opportunities—many of which led to promising initial partnership intentions. 

MedicalSystem will continue working with global partners to drive innovation, strengthen R&D, and deliver high-quality diagnostic solutions, contributing to the advancement of global healthcare through Chinese innovation.